Miles Capital Inc. trimmed its stake in shares of Masimo Corporation (NASDAQ:MASI) by 0.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,756 shares of the medical equipment provider’s stock after selling 18 shares during the period. Miles Capital Inc.’s holdings in Masimo Corporation were worth $251,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. BlackRock Inc. boosted its position in shares of Masimo Corporation by 4,676.3% in the 1st quarter. BlackRock Inc. now owns 7,364,235 shares of the medical equipment provider’s stock valued at $686,789,000 after purchasing an additional 7,210,051 shares during the period. State Street Corp increased its stake in Masimo Corporation by 42.8% in the 1st quarter. State Street Corp now owns 1,401,516 shares of the medical equipment provider’s stock worth $130,704,000 after purchasing an additional 419,767 shares in the last quarter. Acadian Asset Management LLC increased its stake in Masimo Corporation by 28.0% in the 2nd quarter. Acadian Asset Management LLC now owns 1,791,597 shares of the medical equipment provider’s stock worth $163,356,000 after purchasing an additional 392,410 shares in the last quarter. JPMorgan Chase & Co. increased its stake in Masimo Corporation by 76.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 802,698 shares of the medical equipment provider’s stock worth $73,191,000 after purchasing an additional 347,360 shares in the last quarter. Finally, Vanguard Group Inc. increased its stake in Masimo Corporation by 6.9% in the 2nd quarter. Vanguard Group Inc. now owns 4,935,693 shares of the medical equipment provider’s stock worth $450,036,000 after purchasing an additional 318,060 shares in the last quarter. 83.21% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “Masimo Corporation (MASI) Stake Lessened by Miles Capital Inc.” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/10/02/masimo-corporation-masi-stake-lessened-by-miles-capital-inc.html.

MASI has been the subject of a number of analyst reports. BidaskClub raised shares of Masimo Corporation from a “hold” rating to a “buy” rating in a research note on Wednesday, July 12th. Stifel Nicolaus initiated coverage on shares of Masimo Corporation in a report on Monday, July 10th. They issued a “buy” rating and a $105.00 target price for the company. Roth Capital lifted their target price on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, July 19th. BTIG Research raised shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research report on Monday, August 14th. Finally, Zacks Investment Research lowered shares of Masimo Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $95.00.

Shares of Masimo Corporation (NASDAQ MASI) traded up 0.96% on Monday, reaching $87.39. 44,726 shares of the company were exchanged. Masimo Corporation has a 12 month low of $53.78 and a 12 month high of $104.71. The stock has a market capitalization of $4.54 billion, a P/E ratio of 14.32 and a beta of 0.82. The stock has a 50 day moving average price of $85.78 and a 200-day moving average price of $90.95.

Masimo Corporation (NASDAQ:MASI) last issued its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.12. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The business had revenue of $192.90 million during the quarter, compared to analyst estimates of $189.03 million. During the same period in the previous year, the firm earned $0.57 EPS. Masimo Corporation’s quarterly revenue was up 11.8% compared to the same quarter last year. On average, equities analysts expect that Masimo Corporation will post $2.80 EPS for the current fiscal year.

In other news, insider Jon Coleman sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, July 20th. The shares were sold at an average price of $97.50, for a total value of $2,437,500.00. Following the completion of the transaction, the insider now owns 32,201 shares in the company, valued at $3,139,597.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Sanford Fitch sold 11,000 shares of the company’s stock in a transaction that occurred on Thursday, August 17th. The shares were sold at an average price of $87.25, for a total transaction of $959,750.00. Following the completion of the transaction, the director now owns 72,249 shares of the company’s stock, valued at approximately $6,303,725.25. The disclosure for this sale can be found here. Over the last three months, insiders have sold 112,000 shares of company stock valued at $10,444,090. 16.60% of the stock is owned by company insiders.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.